More than half (8/15; 53.3%) of our cases were mutation carriers of genes for Fanconi anemia, and among the genes, BRCA2 and PALB2 are known to be associated with other cancers, including breast and ovarian cancers. This evidence concerns the gene PALB2 and ovarian cancer.